Oncolytic Bioweapon: Engineered Bacteria to Deploy Viruses that Attack Cancer Cells
CAPPSID – an engineered partnership between bacteria and an oncolytic virus,...
CAPPSID – an engineered partnership between bacteria and an oncolytic virus,...
Clinicians had noted that many women diagnosed with peripartum cardiomyopathy...
Green light from MHRA for Krazati (Adagrasib) – that targets NSCLC....
Mobile stroke units (MSUs) have emerged as a game-changer in prehospital stroke...
AstraZeneca's new drug – Sipavibart, represents a significant step forward in...
In a stride toward advancing neonatal and paediatric care, Owen Mumford, a...
Restoring extinct species stands at the forefront of scientific innovation, and...